LR
Laxmana Ranjal Shenoy
About Laxmana Ranjal Shenoy
Data last updated:
Laxmana Ranjal Shenoy is a Director at Alkem Laboratories Limited (since 2025) and Director at Indchemie Health Specialities Private Limited (since 2025). The companies operate in Pharma, Chemicals and Materials and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹16,030 Cr; the largest is Alkem Laboratories Limited at ₹15,296 Cr (FY 2026). Earlier, Laxmana Ranjal Shenoy was a Director at Sunshield Chemicals Limited (2015–2025) and Director at Elantas Beck India Limited (2013–2024) and 7 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alkem Laboratories Limited L00305MH1973PLC174201 | Director | 13 Jul 2025 | 1973 | ₹15,296 Cr (FY 2026) | Active |
 Indchemie Health Specialities Private Limited U24230MH1986PTC039692 | Director | 18 Jul 2025 | 1986 | ₹734 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunshield Chemicals Limited L99999MH1986PLC041612 | Director | 20 Mar 2015 | 1986 | ₹444 Cr (FY 2026) | Active |
 Elantas Beck India Limited L24222PN1956PLC134746 | Director | 28 Oct 2013 | 1956 | ₹803 Cr (FY 2024) | Active |
 Procter & Gamble Health Limited L99999MH1967PLC013726 | Whole-Time Director | 27 Dec 1988 | 1967 | ₹945 Cr (FY 2025) | Active |
 Transwarranty Finance Limited L65920MH1994PLC080220 | Director | 28 Jan 2013 | 1994 | ₹15.74 Cr (FY 2025) | Active |
 Sahajanand Medical Technologies Limited U33119GJ2001PLC040121 | Director | 01 Jun 2021 | 2001 | ₹1,036 Cr (FY 2025) | Active |
 Shrenuj And Company Limited L99999MH1982PLC026903 | Additional Director | 21 Mar 2017 | 1982 | ₹5,505 Cr (FY 2015) | Under Liquidation |
 Merck Specialities Private Limited U24100MH2005PTC152680 | Director | 18 Apr 2005 | 2005 | ₹1,027 Cr (FY 2025) | Active |
 Enzene Biosciences Limited U24232PN2006PLC165610 | Additional Director | 09 Feb 2017 | 2006 | ₹385 Cr (FY 2025) | Active |
 Bangalore Genei (India) Private Limited U33112MH2009PTC198023 | Additional Director | 11 Oct 2009 | 2009 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Laxmana Ranjal Shenoy
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Laxmana Ranjal Shenoy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laxmana Ranjal Shenoy
Laxmana Ranjal Shenoy currently holds 2 directorships: Alkem Laboratories Limited (Director, since 13 Jul 2025, revenue ₹15,296 Cr (FY 2026)); Indchemie Health Specialities Private Limited (Director, since 18 Jul 2025, revenue ₹734 Cr (FY 2025)).
Laxmana Ranjal Shenoy was first appointed on 27 Dec 1988 as Whole-Time Director at Procter & Gamble Health Limited. The most recent appointment on record is 18 Jul 2025 at Indchemie Health Specialities Private Limited.
The 2 current companies of Laxmana Ranjal Shenoy that report revenue have a combined latest revenue of ₹16,030 Cr: Alkem Laboratories Limited ₹15,296 Cr (FY 2026); Indchemie Health Specialities Private Limited ₹734 Cr (FY 2025).
Laxmana Ranjal Shenoy held 9 earlier board appointments: Sunshield Chemicals Limited (Director, 20 Mar 2015 to 19 Mar 2025); Elantas Beck India Limited (Director, 28 Oct 2013 to 01 Apr 2024); Procter & Gamble Health Limited (Whole-Time Director, 27 Dec 1988 to 30 Sep 2012); Transwarranty Finance Limited (Director, 28 Jan 2013 to 18 Jan 2016); Sahajanand Medical Technologies Limited (Director, 01 Jun 2021 to 31 Jul 2022); and 4 more.
The current boards of Laxmana Ranjal Shenoy's companies include Basudeo Narayan Singh (Alkem Laboratories Limited), Diwakar Gupta (Alkem Laboratories Limited), Madhurima Singh (Alkem Laboratories Limited), Manish Narang (Alkem Laboratories Limited), Mritunjay Kumar Singh (Alkem Laboratories Limited), Narendra Kumar Aneja (Alkem Laboratories Limited), among others.